Causes, Not Just Cases® | The Motley Rice Law Blog

Filter By

Clear Filters
Blog | Motley Rice

March 16, 2015

New train crash technology may be the difference in lives lost due to vehicle collisions

by: Mary F. Schiavo

Two particular technologies are often of great interest to the National Transportation Safety Board whenever they investigate the collision between a vehicle and a train: the effectiveness and application of the crash energy management technology, which can use a number of different technologies to dissipate and absorb the force of impact, and Positive Train Control.

Read More
Blog | Motley Rice

February 25, 2015

Seventeen years after Master Settlement Agreement, another historic tobacco settlement reached for victims

by: Joseph F. Rice

Today, I am proud to have served as chief negotiator for another historic tobacco-related settlement – a $100 million aggregate settlement with Lorillard Tobacco Company, Philip Morris USA, R.J. Reynolds Tobacco Company, for hundreds of individual smokers that are part of the Engle-progeny tobacco cases pending in the Florida federal district court.

Read More
Blog | Motley Rice

February 4, 2015

The blind oversight of the auto industry

by: Kevin R. Dean

62 million. That’s how many vehicles were recalled by automakers in the United States in 2014. To put that in perspective, that’s about one car for every five on the road. And while GM holds a significant stake in that total with more than 80 separate recalls affecting close to 27 million automobiles just in North America, the Takata airbag issue also had a significant role in pushing this frightening number to its record breaking total.

Read More
Blog | Motley Rice

December 19, 2014

Trouble with Tylenol®: Even common OTC medication should be taken with care

by: Carmen S. Scott

When the risk of severe, potentially deadly skin reactions is found in association with one of the most widely used over-the-counter medications, you would think that warning the public would be a priority. But a year and a half after publishing an initial consumer update on the risk, the FDA is only now asking that a warning be placed on all acetaminophen-containing medications, including over-the-counter drugs.

Read More